# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA5278465 | 33 | IC50 | > | 2 | uM | ALA5252875 | nM | Homo sapiens | |||
2. | ALA5288565 | 29 | IC50 | > | 2 | uM | ALA5252875 | nM | Homo sapiens | |||
3. | WZ 4003 | WZ4003 | % of kinase activity | = | 33 | % | ALA5212902 | % | Homo sapiens | |||
4. | Mps1-IN-2 | BDBM36486 | IC50 | = | 5000 | nM | ALA5212758 | 5.30 | nM | Homo sapiens | ||
5. | BAY-293 | EUB0000320 | % of control | = | 45 | % | ALA5213877 | % | Homo sapiens | |||
6. | ALA5202126 | 36 | INH | = | 92 | % | ALA5155841 | % | Homo sapiens | |||
7. | MARK4 inhibitor 1 | 9g | INH | 0 | ALA4412655 | Not Active | % | Homo sapiens | ||||
8. | ALA4455923 | 48c | INH | < | 50 | % | ALA4405579 | % | Homo sapiens | |||
9. | ALA4559936 | (+/-)-6 | Activity | = | 6.7 | % | ALA4391597 | % | Homo sapiens | |||
10. | ALA4564973 | 50 | INH | = | 55 | % | ALA4389971 | % | Homo sapiens | |||
11. | ALA4555459 | 43 | INH | = | 100 | % | ALA4389494 | % | Homo sapiens | |||
12. | ALA4545456 | 24 | INH | = | 50 | % | ALA4387360 | % | Homo sapiens | |||
13. | Abemaciclib | ABEMACICLIB | INH | = | 50.8 | % | ALA4387360 | % | Homo sapiens | |||
14. | ALA4473365 | 7c | Activity | = | 2 | % | ALA4382775 | % | Homo sapiens | |||
15. | ALA4438748 | 12j | IC50 | > | 10 | uM | ALA4379451 | nM | Homo sapiens | |||
16. | CDK9-IN-7 | 21e | INH | = | 27 | % | ALA4377918 | % | Homo sapiens | |||
17. | Dasatinib | 2, BMS-354825 | Activity | > | 75 | % | ALA4808014 | % | Homo sapiens | |||
18. | ALA4855726 | B3 | Activity | > | 75 | % | ALA4808014 | % | Homo sapiens | |||
19. | ALA4867844 | C7 | Activity | > | 75 | % | ALA4808014 | % | Homo sapiens | |||
20. | ALA2348350 | 15u | Activity | = | 100 | % | ALA4806784 | % | Homo sapiens |